首页> 外文期刊>International journal of pediatric otorhinolaryngology >Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment.
【24h】

Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment.

机译:鼻内曲安奈德对季节性变应性鼻炎患儿支气管高反应性的影响,并通过声鼻测鼻法比较感觉性鼻塞。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Many patients with allergic rhinitis (AR) have bronchial hyper-responsiveness (BHR), and seasonal variation of BHR has been demonstrated in these patients. We aimed to investigate how BHR in children with seasonal AR is modified by triamcinolone acetonide aqueous nasal spray (TANS) therapy during the pollen season. A secondary aim was to assess the efficacy of TANS on nasal congestion by acoustic rhinometry and symptom scores. METHODS: A total of 34 children aged 7-18 years with grass pollen-induced AR and 18 age and sex-matched healthy controls were included in study. The patients were divided into the following two subgroups: 22 patients who had AR only; and 12 patients who had AR and asthma. All of them had a baseline BHR (PC20FEV1 methacholine < 8mg/ml). All patients received 220 microg TANS once daily for 4 weeks following a 1-week run-in period. Nasal patency was measured by acoustic rhinometry and patients recorded their nasal obstruction scores in a diary. RESULTS: There was no significant difference at baseline pulmonary function test parameters between the patients and the healthy control children. None of the control subjects had BHR. Asthmatic children with AR had significantly reduced baseline PC20FEV1 when compared with the AR only group [mean +/- S.E.M., (1.60 +/- 0.57 mg/ml versus 2.93 +/- 0.42 mg/ml, P = 0.021)]. The mean PC20FEV1 values increased slightly at the end of treatment in both group (from 1.60 +/- 0.57 mg/ml to 3.25 +/- 1.11 and from 2.93 +/- 0.42 mg/ml to 3.93 +/- 1.41 mg/ml), but the change was not statistically significant. TANS produced substantial symptomatic recovery in nasal obstruction according to patients' daily diary assessments, and significantly improved all objective acoustic rhinometry parameters. CONCLUSIONS: Once-daily intranasal TANS 220 microg effectively controlled nasal obstruction in children with seasonal AR according to subjective and objective assessments, and blocked the increase in BHR to methacholine after high-load natural pollen exposure. There was no correlation between patients' own subjective assessment of nasal obstruction and objective acoustic rhinometric assessment.
机译:目的:许多过敏性鼻炎(AR)患者具有支气管高反应性(BHR),并且已证明这些患者的BHR存在季节性变化。我们的目的是研究在花粉季节如何通过曲安奈德鼻腔喷鼻(TANS)治疗来改善季节性AR儿童的BHR。第二个目的是通过声鼻法和症状评分来评估TANS对鼻充血的疗效。方法:共有34名7-18岁的儿童患有草花粉诱发的AR,以及18名年龄和性别相匹配的健康对照者。将这些患者分为以下两个亚组:22例仅患有AR的患者; 3例仅患有AR的患者。 12例患有AR和哮喘的患者。所有患者均具有基线BHR(PC20FEV1乙酰甲胆碱<8mg / ml)。在为期1周的磨合期后的4周中,所有患者每天一次接受220微克TANS的治疗。鼻通畅度通过声学鼻旋光度法测量,患者在日记中记录鼻塞分数。结果:在基线肺功能测试参数与患者和健康对照儿童之间没有显着差异。对照组均无BHR。与单纯AR组相比,患有AR的哮喘儿童的基线PC20FEV1明显降低[平均值+/- S.E.M。,(1.60 +/- 0.57 mg / ml与2.93 +/- 0.42 mg / ml,P = 0.021)]。两组治疗结束时的平均PC20FEV1值均略有增加(从1.60 +/- 0.57 mg / ml增至3.25 +/- 1.11和从2.93 +/- 0.42 mg / ml增至3.93 +/- 1.41 mg / ml) ,但变化没有统计学意义。根据患者的日常日记评估,TANS可显着改善鼻塞的症状,并显着改善所有客观的声学流变仪参数。结论:根据主观和客观评估,每日一次鼻内TANS 220微克有效控制了季节性AR儿童的鼻塞,并阻止了高负荷天然花粉暴露后甲乙胆碱的BHR升高。患者自己对鼻塞的主观评估与客观声鼻鼻炎评估之间没有关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号